营养药在自主功能和相关疾病的管理:一个全面的审查
Paulo César Trindade Costa1, Micaelle Oliveira de Luna Freire2, Daniella de Oliveira Coutinho2
1Department of Nutrition, Federal University of Paraíba, João Pessoa, PB, Brazil; Laboratoire CarMeN, INSERM U.1060, INRAe U. 1397, Université Claude Bernard Lyon1, Pierre Bénite, France.
Pharmacological research
|August 27, 2024
概括
营养药物在管理自主功能障碍方面表现有前途,为药品提供更安全的替代品. 需要进一步的研究来证实它们对肥胖和心脏代谢疾病等疾病的益处.
科学领域:
- 营养科学 营养科学
- 药理学 药理学是指药理学的学科.
- 自主神经科学 自主神经科学
背景情况:
- 来自植物或动物的营养药,提供健康益处,并且由于潜在的副作用,被探索为药品的替代品.
- 自主功能障碍与肥胖,动脉样硬化和心脏代谢疾病等疾病有关,对新的治疗方法越来越感兴趣.
研究的目的:
- 审查和讨论各种营养药对自主控制的影响的科学文献.
- 探索营养药物影响自主功能的机制,包括肠道微生物群调节和细胞改善.
主要方法:
- 关于营养药和自主功能障碍的实验和临床研究的文献综述.
- 分析有关肠道微生物群调节,生物活性化合物代谢和细胞膜性质的证据.
主要成果:
- 一些营养药物,包括益生菌,白醇,素,黄素和n-3多不和脂肪酸 (n-3PUFA),在动物模型和人体试验中显示出改善自主功能障碍的潜力.
- 机制包括调节肠道微生物群,产生有益的二次代谢产物,增强细胞膜功能.
结论:
- 营养药物是一种有前途的辅助疗法,用于自主功能障碍和相关疾病.
- 进一步的人体研究是必要的,以验证多目标营养药配方的疗效,并阐明它们的作用机制.
相关概念视频
Autonomic Nervous System
8.7K
The autonomic nervous system (ANS) is a critical component of the peripheral nervous system, primarily responsible for regulating involuntary bodily functions and maintaining homeostasis. It functions in tandem with the central nervous system (CNS) to seamlessly coordinate various physiological processes without the need for conscious control.
The ANS comprises two main divisions: the sympathetic and parasympathetic divisions. These divisions function antagonistically to maintain a dynamic...
The ANS comprises two main divisions: the sympathetic and parasympathetic divisions. These divisions function antagonistically to maintain a dynamic...
8.7K
Disorders of the Autonomic Nervous System
590
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
Raynaud's disease, also known as Raynaud's...
590
Antianginal Drugs: Nitrates and β-Blockers
550
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
550
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
405
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
405
Parasympathetic Division of the ANS
2.0K
The parasympathetic division of the autonomic nervous system (ANS) regulates rest and digestion functions in the body. It works in opposition to the sympathetic division, promoting relaxation, conservation of energy, and digestion. The parasympathetic division consists of preganglionic fibers originating from specific cranial nerves (III, VII, IX, X) and the sacral spinal nerves (S2-S4). These fibers synapse with postganglionic neurons in the terminal ganglia, innervating various organs and...
2.0K
Drugs Acting on Autonomic Ganglia: Blockers
980
Ganglionic blockers inhibit autonomic activity by blocking nicotinic receptors in the autonomic ganglia, suppressing impulse transmission. These blockers lack selectivity between sympathetic and parasympathetic ganglia and are ineffective as neuromuscular junction antagonists. They can be categorized into two groups:
980


